Phoenix Holdings Ltd. Amgen Inc Transaction History

Phoenix Holdings Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $798,497 - $970,383	-3,039 Reduced 67.4%	1,470 $459,000
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $1.21 Million - $1.46 Million	4,509 New	4,509 $1.28 Million
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $876,652 - $974,909	-3,736 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$197.81 - $242.74 $159,632 - $195,891	807 Added 27.55%	3,736 $832,000
Q1 2020 May 20, 2020	BUY	$182.24 - $241.7 $533,780 - $707,939	2,929 New	2,929 $580,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.